Archived Content

Information identified as archived on the Web is for reference, research or recordkeeping purposes. It has not been altered or updated after the date of archiving. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats on the "Contact Us" page.

Health Canada is the federal department responsible for helping the people of Canada maintain and improve their health.We assess the safety of drugs and many consumer products, help improve the safety of food, and provide information to Canadians to help them make healthy decisions. We provide health services to First Nations people and to Inuit communities. We work with the provinces to ensure our health care system serves the needs of Canadians.

Background

Bisphenol A (BPA) is the common name for 2,2-(4,4'-dihydroxydiphenyl)propane, 4,4'-isopropylidenediphenol, or 2,2'-bis(4-hydroxyphenyl)propane. It is used as an intermediate in the production of epoxy resins which are used in the internal coating for food and beverage cans to protect the food from direct contact with metal. BPA can migrate from cans with epoxy coating into foods, especially at elevated temperatures (for example, for hot-fill or heat-processed canned foods). BPA is one of the 23000 chemical substances on the CEPA (Canadian Environmental Protection Act) Domestic Substance List (DSL) identified for further evaluation under government of Canada's Chemical Management Plan (CMP).

BPA was included in Batch 2 of the Challenge under CMP carried out by Health Canada and Environment Canada. On October 18, 2008, the Government of Canada released its final assessment report, including the Government’s proposed risk management approaches to reduce Canadian exposure to BPA. Health Canada has committed to a research and monitoring agenda to further investigate potential human health effects of BPA and improve its understanding of Canadian exposure to this chemical through food sources. The purpose of this survey was to gather occurrence levels of BPA in canned powdered infant formula products to contribute in updating the BPA exposure estimate for Canadians.

Sampling Plan and Analytical Methodology

The survey covered 38 canned powdered infant formula products marketed under 11 brands by 6 different companies. The products were purchased in June 2008 from local grocery stores in Ottawa. Among the 38 products, 31 products were milk based and 7 were soya based.

Health Canada continually works to develop more sensitive methods with detection limits as low as possible for the determination of chemicals in foods in order to support more accurate human exposure assessments. The method used previously by Health Canada for determination of BPA in liquid infant formula products was adapted and validated for the determination of BPA in canned powdered infant formula products. This method, with an average method detection limit (MDL) of 0.13 ng/g*, was used to determine levels of BPA in canned powdered infant formula products that are sold in Canada. The results of the analyses for each canned powdered infant formula product collected are shown in Table 1.

Notes:

Canned powdered infant formula samples were tested as consumed.

It should be noted that the absence of any particular brand from this survey means only that the brand was not included in the survey. No particular inference should be drawn from the presence or absence of any brand.

Samples represent a “snapshot” of the market at the time of sampling and do not represent market share. Product names and availability correspond to the time of sampling and may not represent current products on the market. Differences between brands do not necessarily reflect differences in consumer exposure to BPA.

The results shown in Table 1 are generated for research purposes and should not be considered as representative of the distribution of BPA in canned powdered infant formula products or to assist or guide product choices for consumers.

In view of uncertainties related to datasets on possible neurodevelopmental and behavioural effects that BPA may have in experimental animals, Health Canada’s Food Directorate has recommended that precaution be exerted on products consumed by the sensitive subset of the population, i.e. infants and newborns, by applying the ALARA (as low as reasonably achievable) principle to reduce their exposure to BPA through food packaging applications.

Other international food regulatory agencies – notably in the United States, Europe, the United Kingdom and Australia-New Zealand – have reviewed the “Health Risk Assessment of Bisphenol A from Food Packaging Applications+”, prepared by Health Canada’s Food Directorate, and have confirmed that the conclusions reached are supported by the current scientific evidence as described in the document.

Based on the overall weight of evidence, as described in the “Health Risk Assessment of BPA from food packaging applications+", the results of this survey further confirms Health Canada’s previous assessment conclusion that the current dietary exposure to BPA through food packaging uses is not expected to pose a health risk to the consumer.

It should be noted that the absence of any particular brand from this survey means only that the brand was not included in the survey. No particular inference should be drawn from the presence or absence of any brand.

Samples represent a “snapshot” of the market and do not represent market share. Product names and availability correspond to the time of sampling and may not represent current products on the market. Differences between brands do not necessarily reflect differences in consumer exposure to BPA.

The results shown in the table are exploratory and should not be used to indicate the distribution of BPA in canned infant formula products or to assist or guide product choices for consumers.